The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation.
The global Inhalational Anesthesia Drugs market was valued at US$ 1244.1 million in 2023 and is anticipated to reach US$ 1524.1 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Inhalational Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Anesthesia Drugs.
Report Scope
The Inhalational Anesthesia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalational Anesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalational Anesthesia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Companies
- Baxter
- AbbVie
- Piramal Enterprises
- Halocarbon Products
- Jiangsu Hengrui Medicine
- Fresenius Kabi
Segment by Type
- Sevoflurane
- Desflurane
- Isoflurane
- Enflurane
Segment by Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalational Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalational Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Inhalational Anesthesia Drugs Market Overview
1.1 Product Overview and Scope of Inhalational Anesthesia Drugs
1.2 Inhalational Anesthesia Drugs Segment by Type
1.2.1 Global Inhalational Anesthesia Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Sevoflurane
1.2.3 Desflurane
1.2.4 Isoflurane
1.2.5 Enflurane
1.3 Inhalational Anesthesia Drugs Segment by Application
1.3.1 Global Inhalational Anesthesia Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Inhalational Anesthesia Drugs Market Size Estimates and Forecasts
1.4.1 Global Inhalational Anesthesia Drugs Revenue 2019-2030
1.4.2 Global Inhalational Anesthesia Drugs Sales 2019-2030
1.4.3 Global Inhalational Anesthesia Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhalational Anesthesia Drugs Market Competition by Manufacturers
2.1 Global Inhalational Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhalational Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhalational Anesthesia Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Inhalational Anesthesia Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalational Anesthesia Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalational Anesthesia Drugs, Product Type & Application
2.7 Inhalational Anesthesia Drugs Market Competitive Situation and Trends
2.7.1 Inhalational Anesthesia Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalational Anesthesia Drugs Players Market Share by Revenue
2.7.3 Global Inhalational Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalational Anesthesia Drugs Retrospective Market Scenario by Region
3.1 Global Inhalational Anesthesia Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhalational Anesthesia Drugs Global Inhalational Anesthesia Drugs Sales by Region: 2019-2030
3.2.1 Global Inhalational Anesthesia Drugs Sales by Region: 2019-2024
3.2.2 Global Inhalational Anesthesia Drugs Sales by Region: 2025-2030
3.3 Global Inhalational Anesthesia Drugs Global Inhalational Anesthesia Drugs Revenue by Region: 2019-2030
3.3.1 Global Inhalational Anesthesia Drugs Revenue by Region: 2019-2024
3.3.2 Global Inhalational Anesthesia Drugs Revenue by Region: 2025-2030
3.4 North America Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.4.1 North America Inhalational Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhalational Anesthesia Drugs Sales by Country (2019-2030)
3.4.3 North America Inhalational Anesthesia Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.5.1 Europe Inhalational Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhalational Anesthesia Drugs Sales by Country (2019-2030)
3.5.3 Europe Inhalational Anesthesia Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalational Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhalational Anesthesia Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhalational Anesthesia Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.7.1 Latin America Inhalational Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhalational Anesthesia Drugs Sales by Country (2019-2030)
3.7.3 Latin America Inhalational Anesthesia Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalational Anesthesia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalational Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhalational Anesthesia Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhalational Anesthesia Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhalational Anesthesia Drugs Sales by Type (2019-2030)
4.1.1 Global Inhalational Anesthesia Drugs Sales by Type (2019-2024)
4.1.2 Global Inhalational Anesthesia Drugs Sales by Type (2025-2030)
4.1.3 Global Inhalational Anesthesia Drugs Sales Market Share by Type (2019-2030)
4.2 Global Inhalational Anesthesia Drugs Revenue by Type (2019-2030)
4.2.1 Global Inhalational Anesthesia Drugs Revenue by Type (2019-2024)
4.2.2 Global Inhalational Anesthesia Drugs Revenue by Type (2025-2030)
4.2.3 Global Inhalational Anesthesia Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Inhalational Anesthesia Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhalational Anesthesia Drugs Sales by Application (2019-2030)
5.1.1 Global Inhalational Anesthesia Drugs Sales by Application (2019-2024)
5.1.2 Global Inhalational Anesthesia Drugs Sales by Application (2025-2030)
5.1.3 Global Inhalational Anesthesia Drugs Sales Market Share by Application (2019-2030)
5.2 Global Inhalational Anesthesia Drugs Revenue by Application (2019-2030)
5.2.1 Global Inhalational Anesthesia Drugs Revenue by Application (2019-2024)
5.2.2 Global Inhalational Anesthesia Drugs Revenue by Application (2025-2030)
5.2.3 Global Inhalational Anesthesia Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Inhalational Anesthesia Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Inhalational Anesthesia Drugs Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Inhalational Anesthesia Drugs Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Piramal Enterprises
6.3.1 Piramal Enterprises Corporation Information
6.3.2 Piramal Enterprises Description and Business Overview
6.3.3 Piramal Enterprises Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Piramal Enterprises Inhalational Anesthesia Drugs Product Portfolio
6.3.5 Piramal Enterprises Recent Developments/Updates
6.4 Halocarbon Products
6.4.1 Halocarbon Products Corporation Information
6.4.2 Halocarbon Products Description and Business Overview
6.4.3 Halocarbon Products Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Halocarbon Products Inhalational Anesthesia Drugs Product Portfolio
6.4.5 Halocarbon Products Recent Developments/Updates
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Corporation Information
6.5.2 Jiangsu Hengrui Medicine Description and Business Overview
6.5.3 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product Portfolio
6.5.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Inhalational Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Inhalational Anesthesia Drugs Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalational Anesthesia Drugs Industry Chain Analysis
7.2 Inhalational Anesthesia Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalational Anesthesia Drugs Production Mode & Process
7.4 Inhalational Anesthesia Drugs Sales and Marketing
7.4.1 Inhalational Anesthesia Drugs Sales Channels
7.4.2 Inhalational Anesthesia Drugs Distributors
7.5 Inhalational Anesthesia Drugs Customers
8 Inhalational Anesthesia Drugs Market Dynamics
8.1 Inhalational Anesthesia Drugs Industry Trends
8.2 Inhalational Anesthesia Drugs Market Drivers
8.3 Inhalational Anesthesia Drugs Market Challenges
8.4 Inhalational Anesthesia Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
